(redirected from Hybrid Capture II)
HCIIHuman-Computer Interaction Institute (Carnegie Mellon University)
HCIIHuman-Computer Interaction International (conference)
HCIIHuman-Computer Intelligent Interaction (research)
HCIIHybrid Capture II (assay)
HCIIHealth Care Information Infrastructure (National Information Infrastructure subset)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
More than 3,000 women were tested pan-India between 2013 and 2017 for High Risk HPV infection by using the global standard method - Hybrid Capture II.
Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method.
A study from Allahabad, India, reported 27.4% HPV detection in OSF while it was detected in 31.53% cases of OSCC on brush biopsy specimen by Hybrid Capture II test.
(5) The Hybrid Capture II (Qiagen) is a method widely used in many countries and is able to detect 18 HPV types.
Patients with atypical epithelial cells on cytological smear underwent parallel testing for high-risk HPV types with the Hybrid Capture II system.
Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests.
Participants were selected to undergo a primary HPV DNA test (hybrid capture II) with cytology triage if the result was positive, or a conventional cytologic screening.
For high-risk HPV only the swabs were adequate using one of the laboratory tests (Digene Hybrid Capture II), but both the tampon and swab were acceptable when a second test (Roche Reverse Line Blot Assay) was used.
trachomatis testing using Digene's Hybrid Capture II CT-ID test (Digene Corp., Gaithersburg, Maryland, United States).
This study was undertaken to compare the diagnostic accuracy of HPV testing by hybrid capture II (HC-II) with conventional cervical smear cytology for squamous intraepithelial lesions (SIL).
In a separate vote, ACIP also recommended vaccination for women with an equivocal or abnormal Pap test, those who have tested positive for HPV infection using the Hybrid Capture II, and for those with genital warts.